164 related articles for article (PubMed ID: 22564689)
41. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
42. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
Chang HJ; Hsu PC; Yang CC; Siu LK; Kuo AJ; Chia JH; Wu TL; Huang CT; Lee MH
J Antimicrob Chemother; 2012 Mar; 67(3):736-41. PubMed ID: 22169187
[TBL] [Abstract][Full Text] [Related]
43. Methicillin-resistant staphylococcus aureus screening and eradication in the surgical intensive care unit: Is it worth it?
Holmes JW; Williams MD
Am J Surg; 2010 Dec; 200(6):827-30; discussion 830-1. PubMed ID: 21146028
[TBL] [Abstract][Full Text] [Related]
44. Chronicity of high and low level mupirocin resistance in Staphylococcus aureus from 30 Indian hospitals.
Prakash R; Garg A; Arya R; Kumawat RK
Sci Rep; 2023 Jun; 13(1):10171. PubMed ID: 37349503
[TBL] [Abstract][Full Text] [Related]
45. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
Cunha BA; Thekkel V; Schoch P; Cosgrove L
Am J Infect Control; 2011 Apr; 39(3):243-6. PubMed ID: 21145622
[TBL] [Abstract][Full Text] [Related]
46. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
Saderi H; Owlia P; Habibi M
Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
[TBL] [Abstract][Full Text] [Related]
47. The search and destroy strategy prevents spread and long-term carriage of methicillin-resistant Staphylococcus aureus: results from the follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark.
Böcher S; Skov RL; Knudsen MA; Guardabassi L; Mølbak K; Schouenborg P; Sørum M; Westh H
Clin Microbiol Infect; 2010 Sep; 16(9):1427-34. PubMed ID: 20041904
[TBL] [Abstract][Full Text] [Related]
48. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
49. Decreasing methicillin-resistant Staphylococcus aureus surgical site infections with chlorhexidine and mupirocin.
Thompson P; Houston S
Am J Infect Control; 2013 Jul; 41(7):629-33. PubMed ID: 23332373
[TBL] [Abstract][Full Text] [Related]
50. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
51. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
Bouza E
Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():44-52. PubMed ID: 19951334
[TBL] [Abstract][Full Text] [Related]
52. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
53. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.
Liu Y; Kong F; Zhang X; Brown M; Ma L; Yang Y
Br J Dermatol; 2009 Dec; 161(6):1347-50. PubMed ID: 19754868
[TBL] [Abstract][Full Text] [Related]
54. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus.
Harbarth S; Dharan S; Liassine N; Herrault P; Auckenthaler R; Pittet D
Antimicrob Agents Chemother; 1999 Jun; 43(6):1412-6. PubMed ID: 10348762
[TBL] [Abstract][Full Text] [Related]
55. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
56. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
57. Impact of formulary interventions on the minimum inhibitory concentration of methicillin-resistant Staphylococcus aureus to mupirocin, chlorhexidine, and octenidine in a Singapore tertiary institution.
Zheng S; Chung SJ; Sim HCJ; Chlebicka TM; Chan YH; Lim TP; Kwa LHA; Chlebicki MP
Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2397-2403. PubMed ID: 32712737
[TBL] [Abstract][Full Text] [Related]
58. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.
Redhead RJ; Lamb YJ; Rowsell RB
Br J Clin Pract; 1991; 45(4):252-4. PubMed ID: 1810357
[TBL] [Abstract][Full Text] [Related]
59. [Investigation of antibacterial activity of topical antimicrobials against methicillin-resistant Staphylococcus aureus].
Cui S; Han L; Xiao S; Chen X; Chang Q; Liu Y; Zhang X
Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):21-4. PubMed ID: 24684985
[TBL] [Abstract][Full Text] [Related]
60. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin.
Dorrani M; Kaul M; Parhi A; LaVoie EJ; Pilch DS; Michniak-Kohn B
Int J Pharm; 2014 Dec; 476(1-2):199-204. PubMed ID: 25263100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
